Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Looking at skin can help find and treat serious diseases early.

Scientists developed a method to grow human fetal skin and digits in a lab for 3-4 weeks, which could help study skin features and understand genetic interactions in tissue formation.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Immune cells are crucial for hair growth and preventing hair loss.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

The document reviews key historical figures and discoveries in dermatology.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Lasers are effective for some skin conditions but can cause side effects like scarring and pigment changes; careful selection is important, and botulinum toxin type A is successful in reducing sweat in palmar hyperhidrosis.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Understanding gene expression in hair follicles can reveal insights into hair growth and disorders.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.